Short answer
What Novarad actually sells
Novarad has been building radiology software for more than 30 years. NovaPACS is its enterprise imaging platform, offered in cloud, on-premises, edge and hybrid deployments, most customers reportedly running a hybrid of cloud hosting and on-premises storage. Around it sit Nova RIS for patient and workflow management, MobileRAD for mobile EMR, CryptoChart for image sharing, and specialty modules for breast imaging and cardiology. Separately, Novarad also sells VisAR, an FDA-approved augmented-reality navigation system for spine surgery, a genuinely different product from the PACS that should not be read as a claim about NovaPACS itself. Novarad markets an "Evergreen Software" model: upgrades, new features and the newest software version are included for the life of the contract, a real answer to the disruptive-upgrade problem that hits many enterprise PACS deployments.
None of this comes with a published price. Pricing is quoted per facility based on study volume, user count and deployment shape, arrived at through Novarad's own sales process, not posted on the site.
| Novarad NovaPACS | MiniPACS plus Vendo | |
|---|---|---|
| Category | Enterprise imaging platform: PACS, RIS, mobile EMR, AR-surgery nav | Self-hosted PACS with browser viewer, reporting and referral portal |
| Deployment | Cloud, on-premises, edge or hybrid, by contract | Self-hosted, either on hardware in the clinic or on a cloud server in an account the clinic controls |
| Pricing | Quote-only, by facility, study volume and user count | Published flat: $300 a month per location, no per-study fee |
| Upgrades | Evergreen model: upgrades included for the life of the contract | Self-updater with health-gated rollout and automatic, re-verified rollback on failure |
| FDA clearance | NovaPACS holds multiple FDA 510(k) clearances (incl. K171754, K160371) | Not claimed; MiniPACS is workflow, storage and communication, not a submitted diagnostic-display device |
| Independent reviews | Capterra: 4.3/5 across 53 verified reviews; support and ease-of-use both rated 4.4/5 | N/A; MiniPACS is younger and does not claim a review-platform track record either |
| Reported friction (Capterra) | Multiple reviewers cite too many clicks to finish a report and difficulty customizing hanging protocols | Report editor autosaves every 1.5 seconds, expands macros as you type, and preserves anything a physician typed when switching templates mid-report |
| Referral intake | Not the product's job | Vendo: online orders, real slot booking, status tracking |
Where MiniPACS pulls ahead, with the specifics
Novarad is a mature enterprise product, so the honest comparison for a small buyer is about operational depth per dollar, not a feature gap:
One honest caveat: the live worklist is not literally instant from scanner to screen. New studies typically post within about a minute of the last image landing, Orthanc's own 60-second stability window plus a couple of seconds of delivery, pushed live over WebSocket rather than by polling. The browser viewer itself does cold-open a selected study in about 0.6 seconds, measured, which is the number worth quoting for viewer speed.
Moving in is standard DICOM, not a rebuild. MiniPACS receives and sends studies over C-STORE and can bulk-import an existing archive, so a NovaPACS archive moves across as ordinary DICOM rather than a from-scratch reimplementation. Guided remote setup, from $1,500 one time, covers the hardware decision and the migration itself, so a center without in-house IT staff still gets a working handoff. For the step-by-step process, see PACS migration.
Moving in is standard DICOM, not a rebuild.
Comparing quotes? MiniPACS publishes one number: $300 a month per location, or $640 with the Vendo referral portal. Open the live demo, then get pricing.
What Novarad does well, honestly
Novarad earned its position over 30-plus years, serving everything from 500-bed hospitals down to 26-bed critical access facilities, with 24/7 US-based support and claimed integrations across 30-plus healthcare IT partners including Epic, Cerner, Allscripts and athenahealth. Its Evergreen model, upgrades included for the life of the contract, is a genuinely good answer to the disruptive, costly upgrade cycles that hit many enterprise PACS estates, and NovaPACS carries real FDA 510(k) clearances (including K171754 and K160371) that MiniPACS does not hold. Public Capterra reviews back this up with a 4.3-out-of-5 average across 53 verified reviews and specific praise: "Best support in the business" from a two-year customer, and reviewers noting NovaPACS "works for hospitals with less-than-optimal bandwidth," a real strength for rural and lower-bandwidth sites.
The same review set is honest about the rough edges. Reviewers describe needing to click through too many steps to finish a report compared with simpler systems, real difficulty getting hanging protocols configured the way they want, one reviewer describing support as "horrible" and slow to give timely updates, and a specific complaint about how long CD burning takes. None of that erases the strong average rating; it is the honest texture behind it.
Who should choose Novarad vs MiniPACS
What to check before switching
- Get the real quote before comparing. Ask how the quote scales with study volume and user count, then set that trajectory against a flat published number.
- Ask specifically about report-editor click count and hanging protocols. Both are named friction points in NovaPACS's own public reviews; test them yourself with a real study before deciding either way.
- Decide whether you need the RIS and AR-surgery breadth. A single imaging center rarely needs the full enterprise line Novarad sells alongside NovaPACS.
- Check the FDA-clearance requirement for your use case. If a diagnostic-cleared viewer is a hard requirement, confirm that against NovaPACS's 510(k) clearances rather than assuming parity across products in this category.
- Test the export path on a real study. Confirm standard DICOM comes back cleanly whichever deployment model is chosen.
For the broader hosting tradeoff, see cloud PACS vs onsite. For other named comparisons, see Centricity PACS alternative and comparing PACS vendors. For pricing and the live demos, see the landing.
How this comparison is made
This comparison starts with category fit, not a claim that every feature is identical. "Small practice" means an independent imaging center, mobile imaging operator, ASC, dental or veterinary imaging site, or small multi-site group that needs a practical archive and referral workflow without a hospital enterprise imaging program. We compare Novarad and MiniPACS plus Vendo on deployment model, archive ownership, pricing shape, viewer access, backups, referral workflow and the limits each product category handles better.
FAQ
What is Novarad?
Novarad is a radiology software vendor of more than 30 years, best known for NovaPACS, its enterprise imaging platform sold in cloud, on-premises, edge and hybrid deployments. Its line also includes Nova RIS, MobileRAD, CryptoChart for image sharing, and VisAR, an FDA-approved augmented-reality spine-surgery navigation product that is separate from the PACS.
Is MiniPACS a Novarad alternative?
Yes, for an independent center that wants the archive on its own server and one published price instead of a custom quote. MiniPACS is self-hosted, priced flat by location with no per-study fee, and covers the same archive-plus-worklist-plus-reporting job NovaPACS does, without the RIS, AR-surgery and enterprise-hospital scope Novarad also sells.
What is the best Novarad alternative for a small imaging center?
For a center that wants a flat, published price and an archive it controls, either on its own hardware or on a cloud server in its own account, without a quote call, MiniPACS is a strong Novarad alternative. For a hospital, especially one already running Epic, Cerner, Allscripts or athenahealth and needing 500-plus-bed enterprise imaging or its Evergreen upgrade model, NovaPACS is the more direct fit.
How does Novarad pricing compare to MiniPACS?
Novarad does not publish pricing; NovaPACS is quoted per facility based on study volume, user count and deployment model, arrived at through a demo and sales process. MiniPACS publishes one number on its site: $300 a month per location, or $640 a month with the Vendo referral portal, billed yearly, no per-study fee, no quote call required to see it.
Is NovaPACS FDA cleared?
Yes. NovaPACS has multiple FDA 510(k) premarket notification filings on record (including K171754 and K160371) covering viewing, annotation, distribution and processing of DICOM images for use by trained healthcare professionals. MiniPACS does not claim an FDA clearance for its viewer; it is built as a workflow, storage and communication PACS rather than a submitted diagnostic-display device, and that distinction should stay explicit in any comparison.
